🇯🇵 Rupax in Japan

PMDA authorised Rupax on 27 September 2017

Marketing authorisation

PMDA — authorised 27 September 2017

  • Marketing authorisation holder: Teikoku Seiyaku
  • Status: approved

Rupax in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Immunology approved in Japan

Frequently asked questions

Is Rupax approved in Japan?

Yes. PMDA authorised it on 27 September 2017.

Who is the marketing authorisation holder for Rupax in Japan?

Teikoku Seiyaku holds the Japanese marketing authorisation.